GLP-1 medication for hip or knee replacement
Part of Bones, joints & muscles, Hormones & metabolism clinical trials.
This study tests whether a GLP-1 medication (like Ozempic) can help people with obesity who are having hip or knee replacement surgery. It aims to see if the medication improves recovery and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have hip or knee arthritis and are scheduled for joint replacement surgery.
- Your BMI is 40 or higher, or 35 or higher with a related condition like diabetes, high blood pressure, or sleep apnea.
- You are between 18 and 90 years old.
- You are not currently taking a GLP-1 medication (like Ozempic) and have no medical reason to avoid them.
- You are willing to quit smoking before surgery if you smoke.
- You are not taking biologics (like Humira) that weaken the immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a 4-month digital program to help people taking a GLP-1 medication (like Ozempic or Wegovy) make healthy lifestyle changes while they continue the drug. Participants will get guidance and wear a Fitbit to track activity.
This study looks at how GLP-1 receptor agonists (medicines for diabetes or weight loss) affect the results of non-surgical gum disease treatment in adults with overweight and periodontitis. If you are 18-65, have a BMI of 25 or higher, have gum disease, and have at least 20 teeth, you may be eligible. Participants will either continue their usual care or take a GLP-1 medicine, and then receive standard gum treatment.
This trial is an online survey to understand how people taking GLP-1 medications (like Ozempic or Wegovy) are doing with resistance training. If you're an adult on a stable dose of a GLP-1 med for weight or diabetes, your input can help shape better exercise advice.
This study looks at what happens when people taking a GLP-1 medication (like Ozempic) either stop or continue it after weight loss surgery. The goal is to learn whether staying on the medicine helps with long-term weight control.
This study looks at how taking a GLP-1 medicine (like Ozempic or Wegovy) affects your fat tissue before bariatric surgery. It compares people who have taken a GLP-1 for at least 3 months to those who never have.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
Hear when a new Arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.